Ningbo Kway Biotech Co., Ltd.
Ningbo Kway Biotech Co., Ltd. is a China-based company focused on extracting, developing, producing, and selling natural plant-based compositions. The firm emphasizes the utilization of abundant regional resources from northeast China, including Panax Ginseng, American Ginseng, Siberian Ginseng, Schisandra, and Grape Seed, to supply high-quality plant extracts to customers in functional foods, beverages, health products, cosmetics, and pharmaceuticals. Beilun, as one of the region’s major seaports, serves as the company’s logistics gateway, enabling the distribution of its green health products.
Kway Biotech highlights a professional team dedicated to the plant extract industry and leverages ultra-low temperature extraction technology to preserve the original efficacies of plant materials. The company reinforces its commitment to quality through advanced inspection methods and a comprehensive quality control system, positioning its products as environmentally friendly and health-oriented. In the areas of natural plant pesticide residue handling and heavy metal processing, Kway states leadership in the field and alignment with international standards.
The company communicates core values centered on integrity, innovation, environmental protection, and health. Its long-term management philosophy emphasizes quality, service, and sustainable development, with a stated objective of contributing to human health and sharing green health products with a broad audience now and in the future. While the company profile emphasizes scientific development concepts and sustainability, specific business scopes related to international freight, distribution, or logistics services are not detailed in the available material. Overall, Ningbo Kway Biotech presents itself as a manufacturer and supplier of plant-derived extracts, with a focus on quality assurance, environmental responsibility, and health-oriented product offerings.
As a player within the biotech and natural product sector, Kway Biotech positions itself to serve industries that rely on standardized botanicals and extract-based ingredients. The company’s stated capabilities around preserving plant efficacies through low-temperature processing and its adherence to recognized quality standards suggest a manufacturing emphasis rather than a transport-forwarding operation. Prospective partners and customers may seek more information on supply chain capabilities, export readiness, and regulatory compliance for cross-border distribution, which are not explicitly outlined in the current materials but are important considerations for global trade relationships.